Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Change in Accured Expenses (2010 - 2026)

Omeros (OMER) posted Change in Accured Expenses of -$979000.0 for Q1 2026, up 44.15% sequentially from -$1.8 million in Q4 2025, and up 80.58% YoY from -$542132.7 in Q1 2025.

Analysis

Omeros (OMER) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Omeros has reported Change in Accured Expenses for 17 years, with the latest figure at -$979000.0 in Q1 2026.

  • Quarterly Change in Accured Expenses rose 80.58% year-over-year to -$979000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 263.61% YoY) and the FY2025 annual result came in at $4.6 million, up 187.46% from the prior year.
  • Change in Accured Expenses rose to -$979000.0 in Q1 2026 per OMER's latest filing, from -$1.8 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $8.2 million in Q2 2025 and troughed at -$15.7 million in Q1 2022.
  • A 5-year average of -$448176.5 and a median of $879000.0 in 2022 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 781.72% in 2024, then soared 1336.43% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $879000.0 in 2022, then advanced by 7.05% to $941000.0 in 2023, then soared by 544.63% to $6.1 million in 2024, then sank by 128.9% to -$1.8 million in 2025, then soared by 44.15% to -$979000.0 in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$979000.0, -$1.8 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.22 Mn
Mar 31, 2026 -979,000.00
Dec 31, 2025 -1.75 Mn
Sep 30, 2025 3.13 Mn
Jun 30, 2025 8.25 Mn
Mar 31, 2025 -5.04 Mn
Dec 31, 2024 6.07 Mn
Sep 30, 2024 -5.64 Mn
Jun 30, 2024 -667,000.00
Mar 31, 2024 -5.00 Mn
Dec 31, 2023 941,000.00
Sep 30, 2023 982,000.00
Jun 30, 2023 2.03 Mn
Mar 31, 2023 733,000.00
Dec 31, 2022 879,000.00
Sep 30, 2022 1.11 Mn
Jun 30, 2022 3.02 Mn
Mar 31, 2022 -15.67 Mn
Dec 31, 2021 9.84 Mn
Sep 30, 2021 -5.07 Mn